Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10034919 Targeted human-interferon fusion proteins

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
September 27, 2017
Date of Patent
July 31, 2018
Patent Application Number
15717205
Patent Citations Received
‌
US Patent 12091463 Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)
0
‌
US Patent 11566072 CD8 binding agents
0
‌
US Patent 10906985 Targeted engineered interferon and uses thereof
0
‌
US Patent 10946070 Targeted and mutated human-interferon fusion proteins
0
‌
US Patent 11246911 Immune-cell targeted bispecific chimeric proteins and uses thereof
‌
US Patent 11384154 Targeted chimeric proteins and uses thereof
0
‌
US Patent 11440943 Therapeutic interferon alpha 1 proteins
‌
US Patent 12084497 SIRP1α targeted chimeric proteins and uses thereof
0
‌
US Patent 11498966 PD-1 and PD-L1 binding agents
Patent Inventor Names
Franciane Paul
0
Guillaume Cartron
0
Jacob Piehler
0
Jan Tavernier
0
Gilles Uzé
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10034919
Patent Primary Examiner
‌
Daniel E Kolker

Find more entities like US Patent 10034919 Targeted human-interferon fusion proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo